{"transactions":[{"id":730380,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T20:28:00.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":49579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":49579,"derivative":{"exercise_price":1.13,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":49579},"source":{"system":"sec-edgar","filing":"0000905148-26-003054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514826003054/form4.xml","form_type":"4"}},{"id":730379,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:28:00.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":30421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":428749,"source":{"system":"sec-edgar","filing":"0000905148-26-003054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514826003054/form4.xml","form_type":"4"}},{"id":1067673,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-13T23:47:13.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":1.3722,"value":137220.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":398328,"source":{"system":"sec-edgar","filing":"0000905148-25-002875","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825002875/form4.xml","form_type":"4"}},{"id":1103600,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T22:41:47.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50790,"derivative":{"exercise_price":2.11,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":50790},"source":{"system":"sec-edgar","filing":"0000905148-25-002233","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825002233/form4.xml","form_type":"4"}},{"id":1103599,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-23T22:41:47.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":29210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":298328,"source":{"system":"sec-edgar","filing":"0000905148-25-002233","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825002233/form4.xml","form_type":"4"}},{"id":1375189,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-11-05T21:25:05.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":false,"shares":47689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":47689},"source":{"system":"sec-edgar","filing":"0001415889-24-026144","document":"form4-11052024_041101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924026144/form4-11052024_041101.xml","form_type":"4"}},{"id":1375188,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:25:05.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":47689,"price":3.72,"value":177403.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.61 to $3.755, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":269118,"source":{"system":"sec-edgar","filing":"0001415889-24-026144","document":"form4-11052024_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924026144/form4-11052024_041101.xml","form_type":"4"}},{"id":1375187,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:25:05.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":true,"shares":47689,"price":0.04,"value":1907.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."}],"balance_after":316807,"source":{"system":"sec-edgar","filing":"0001415889-24-026144","document":"form4-11052024_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924026144/form4-11052024_041101.xml","form_type":"4"}},{"id":1394009,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-02T21:03:39.000Z","date":"2024-10-02","kind":"exercise","planned":true,"acquired":false,"shares":21607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":47689,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":21607},"source":{"system":"sec-edgar","filing":"0001415889-24-024454","document":"form4-10022024_091036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924024454/form4-10022024_091036.xml","form_type":"4"}},{"id":1394008,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-02T21:03:39.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":26082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":69296,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":26082},"source":{"system":"sec-edgar","filing":"0001415889-24-024454","document":"form4-10022024_091036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924024454/form4-10022024_091036.xml","form_type":"4"}},{"id":1394007,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:03:39.000Z","date":"2024-10-02","kind":"sale","planned":true,"acquired":false,"shares":21607,"price":3.71,"value":80161.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.625 to $3.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":269118,"source":{"system":"sec-edgar","filing":"0001415889-24-024454","document":"form4-10022024_091036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924024454/form4-10022024_091036.xml","form_type":"4"}},{"id":1394006,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:03:39.000Z","date":"2024-10-02","kind":"exercise","planned":true,"acquired":true,"shares":21607,"price":0.04,"value":864.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."}],"balance_after":290725,"source":{"system":"sec-edgar","filing":"0001415889-24-024454","document":"form4-10022024_091036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924024454/form4-10022024_091036.xml","form_type":"4"}},{"id":1394005,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:03:39.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":26082,"price":3.78,"value":98589.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $3.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":269118,"source":{"system":"sec-edgar","filing":"0001415889-24-024454","document":"form4-10022024_091036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924024454/form4-10022024_091036.xml","form_type":"4"}},{"id":1394004,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:03:39.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":26082,"price":0.04,"value":1043.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."}],"balance_after":295200,"source":{"system":"sec-edgar","filing":"0001415889-24-024454","document":"form4-10022024_091036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924024454/form4-10022024_091036.xml","form_type":"4"}},{"id":1413699,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-05T21:10:41.000Z","date":"2024-09-04","kind":"exercise","planned":true,"acquired":false,"shares":29767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":95378,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":29767},"source":{"system":"sec-edgar","filing":"0001415889-24-022941","document":"form4-09052024_090936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924022941/form4-09052024_090936.xml","form_type":"4"}},{"id":1413698,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-05T21:10:41.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":17922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":125145,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":17922},"source":{"system":"sec-edgar","filing":"0001415889-24-022941","document":"form4-09052024_090936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924022941/form4-09052024_090936.xml","form_type":"4"}},{"id":1413697,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T21:10:41.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":29767,"price":3.97,"value":118174.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.90 to $4.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":269118,"source":{"system":"sec-edgar","filing":"0001415889-24-022941","document":"form4-09052024_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924022941/form4-09052024_090936.xml","form_type":"4"}},{"id":1413696,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T21:10:41.000Z","date":"2024-09-04","kind":"exercise","planned":true,"acquired":true,"shares":29767,"price":0.04,"value":1190.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."}],"balance_after":298885,"source":{"system":"sec-edgar","filing":"0001415889-24-022941","document":"form4-09052024_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924022941/form4-09052024_090936.xml","form_type":"4"}},{"id":1413695,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T21:10:41.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":17922,"price":4.1,"value":73480.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.04 to $4.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":269118,"source":{"system":"sec-edgar","filing":"0001415889-24-022941","document":"form4-09052024_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924022941/form4-09052024_090936.xml","form_type":"4"}},{"id":1413694,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T21:10:41.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":17922,"price":0.04,"value":716.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024."}],"balance_after":287040,"source":{"system":"sec-edgar","filing":"0001415889-24-022941","document":"form4-09052024_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924022941/form4-09052024_090936.xml","form_type":"4"}},{"id":1480421,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T21:37:03.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":40701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40701,"derivative":{"exercise_price":4.68,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":40701},"source":{"system":"sec-edgar","filing":"0001415889-24-016711","document":"form4-06132024_090659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924016711/form4-06132024_090659.xml","form_type":"4"}},{"id":1480420,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T21:37:03.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":21367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":269118,"source":{"system":"sec-edgar","filing":"0001415889-24-016711","document":"form4-06132024_090659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924016711/form4-06132024_090659.xml","form_type":"4"}},{"id":1845052,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T21:36:35.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 22, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.57,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-039480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919123039480/doc4.xml","form_type":"4"}},{"id":2084252,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-12-16T22:00:48.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":6966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":6967,"derivative":{"underlying":"Common Stock","underlying_shares":6966},"source":{"system":"sec-edgar","filing":"0001209191-22-061699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122061699/doc4.xml","form_type":"4"}},{"id":2084251,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-16T22:00:48.000Z","date":"2022-12-14","kind":"tax_withholding","acquired":false,"shares":2320,"price":17.23,"value":39973.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares reported on this Form 4 are subject to a lock-up agreement between the Reporting Person, J.P. Morgan Securities LLC and Jefferies LLC, dated December 14, 2022."}],"balance_after":36492,"source":{"system":"sec-edgar","filing":"0001209191-22-061699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122061699/doc4.xml","form_type":"4"}},{"id":2084250,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-16T22:00:48.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":6966,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were received by the Reporting Person in connection with vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":38812,"source":{"system":"sec-edgar","filing":"0001209191-22-061699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122061699/doc4.xml","form_type":"4"}},{"id":2150108,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-28T21:02:58.000Z","date":"2022-09-26","kind":"exercise","acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001209191-22-051472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122051472/doc4.xml","form_type":"4"}},{"id":2150107,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-28T21:02:58.000Z","date":"2022-09-26","kind":"tax_withholding","acquired":false,"shares":2180,"price":18.87,"value":41136.6,"ownership":{"direct":true},"balance_after":31846,"source":{"system":"sec-edgar","filing":"0001209191-22-051472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122051472/doc4.xml","form_type":"4"}},{"id":2150106,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-28T21:02:58.000Z","date":"2022-09-26","kind":"exercise","acquired":true,"shares":6546,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":34026,"source":{"system":"sec-edgar","filing":"0001209191-22-051472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122051472/doc4.xml","form_type":"4"}},{"id":2209813,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-08T20:04:16.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":26900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":26900,"derivative":{"exercise_price":4.82,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":26900},"source":{"system":"sec-edgar","filing":"0001209191-22-041608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919122041608/doc4.xml","form_type":"4"}},{"id":2336249,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-14T23:43:57.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":41474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":41474,"derivative":{"underlying":"Common Stock","underlying_shares":41474},"source":{"system":"sec-edgar","filing":"0001209191-22-018656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122018656/doc4.xml","form_type":"4"}},{"id":2336248,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T23:43:57.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":62211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on the first anniversary of the March 10, 2022 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":62211,"derivative":{"exercise_price":77.77,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":62211},"source":{"system":"sec-edgar","filing":"0001209191-22-018656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122018656/doc4.xml","form_type":"4"}},{"id":2470454,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-12-16T22:14:30.000Z","date":"2021-12-14","kind":"exercise","acquired":false,"shares":6967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":13933,"derivative":{"underlying":"Common Stock","underlying_shares":6967},"source":{"system":"sec-edgar","filing":"0001209191-21-070007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121070007/doc4.xml","form_type":"4"}},{"id":2470453,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-16T22:14:30.000Z","date":"2021-12-14","kind":"tax_withholding","acquired":false,"shares":3366,"price":168.43,"value":566935.38,"ownership":{"direct":true},"balance_after":27480,"source":{"system":"sec-edgar","filing":"0001209191-21-070007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121070007/doc4.xml","form_type":"4"}},{"id":2470452,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-16T22:14:30.000Z","date":"2021-12-14","kind":"exercise","acquired":true,"shares":6967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":30846,"source":{"system":"sec-edgar","filing":"0001209191-21-070007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121070007/doc4.xml","form_type":"4"}},{"id":2550030,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"exercise","acquired":false,"shares":10829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Vesting of the shares subject to this option grant under the Plan were subject to the satisfaction of both (1) a time-based vesting requirement, pursuant to which twenty-five percent (25%) of the shares vested on the first anniversary of the November 14, 2016 grant date, and the remaining seventy-five percent (75%) of the shares vested in equal monthly installments on the first of each month over the following three (3) years subject to continued employment through such vesting date, and (2) a performance-based vesting requirement, pursuant to which 33.33%, 33.33%, and 33.34% of the shares vested, if at any time during the four-year period from the November 14, 2016 grant date, the volume-weighted average stock price of the Company's common stock met or exceeded $80.00, $120.00, or $160.00, respectively, for twenty (20) consecutive trading days. The Company's common stock did not meet $160.00 for twenty (20) consecutive trading days and therefore 9,171 shares were cancelled."}],"balance_after":0,"derivative":{"exercise_price":27,"expiration_date":"2026-11-14","underlying":"Common Stock","underlying_shares":10829},"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550029,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"exercise","acquired":false,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Company Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the December 15, 2017 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years subject to continued employment through each such vesting date."}],"balance_after":36499,"derivative":{"exercise_price":27.6,"expiration_date":"2027-12-15","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550028,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":500,"price":180.58,"value":90290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.31 to $180.74, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":23879,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550027,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":3300,"price":179.4794,"value":592282.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.05 to $180.00, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":24379,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550026,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":8563,"price":178.4634,"value":1528182.0942,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.04 to $178.98, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":27679,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550025,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":8890,"price":177.5843,"value":1578724.427,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.03 to $178.02, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":36242,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550024,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":4700,"price":176.4753,"value":829433.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.01 to $176.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":45132,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550023,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":3600,"price":175.6106,"value":632198.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.01 to $175.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":49832,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550022,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":3100,"price":174.5619,"value":541141.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.01 to $174.97, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":53432,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550021,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":5038,"price":173.4476,"value":873829.0088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.93 to $173.92, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":56532,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550020,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":3746,"price":172.3631,"value":645672.1726,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.92 to $172.88, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":61570,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550019,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":1392,"price":166.9835,"value":232441.032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.94 to $167.04, inclusive. The reporting person undertakes to provide to Novavax, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":65316,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550018,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"exercise","acquired":true,"shares":10829,"price":27,"value":292383.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":66708,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550017,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:05:23.000Z","date":"2021-10-04","kind":"exercise","acquired":true,"shares":32000,"price":27.6,"value":883200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":55879,"source":{"system":"sec-edgar","filing":"0001209191-21-059557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059557/doc4.xml","form_type":"4"}},{"id":2550016,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F24","text":"Vesting of the shares subject to this option grant under the Plan were subject to the satisfaction of both (1) a time-based vesting requirement, pursuant to which twenty-five percent (25%) of the shares vested on the first anniversary of the November 14, 2016 grant date, and the remaining seventy-five percent (75%) of the shares vested in equal monthly installments on the first of each month over the following three (3) years subject to continued employment through such vesting date, and (2) a performance-based vesting requirement, pursuant to which 33.33%, 33.33%, and 33.34% of the shares vested, if at any time during the four-year period from the November 14, 2016 grant date, the volume-weighted average stock price of the Company's common stock met or exceeded $80.00, $120.00, or $160.00, respectively, for twenty (20) consecutive trading days. The Company's common stock did not meet $160.00 for twenty (20) consecutive trading days and therefore 9,171 shares were cancelled."}],"balance_after":10829,"derivative":{"exercise_price":27,"expiration_date":"2026-11-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550015,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F23","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Company Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the December 15, 2017 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years subject to continued employment through each such vesting date."}],"balance_after":68499,"derivative":{"exercise_price":27.6,"expiration_date":"2027-12-15","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550014,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":472,"price":190.632,"value":89978.304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F22","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.63 to $190.95, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":23879,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550013,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1502,"price":189.4701,"value":284584.0902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.07 to $189.95, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":24351,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550012,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":100,"price":187.95,"value":18795.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":25853,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550011,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":8,"price":185.71,"value":1485.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":25953,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550010,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":192,"price":183.6104,"value":35253.1968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.60 to $183.62, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":25961,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550009,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":300,"price":182.4033,"value":54720.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.88 to $182.83, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":26153,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550008,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1600,"price":181.2088,"value":289934.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.88 to $181.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":26453,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550007,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":2541,"price":180.4239,"value":458457.1299,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.88 to $180.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":28053,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550006,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1323,"price":179.2895,"value":237200.0085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.87 to $179.84, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":30594,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550005,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":4604,"price":178.2695,"value":820752.778,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.82 to $178.75, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":31917,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550004,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":6227,"price":177.3686,"value":1104474.2722,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.80 to $177.75, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":36521,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550003,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":2601,"price":176.2353,"value":458388.0153,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.79 to $176.55, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":42748,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550002,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":3602,"price":175.1465,"value":630877.693,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.74 to $175.72, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":45349,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550001,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":5853,"price":174.2996,"value":1020175.5588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.72 to $174.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":48951,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2550000,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":3002,"price":173.1625,"value":519833.825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.67 to $173.63, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":54804,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549999,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":4103,"price":172.0242,"value":705815.2926,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.66 to $172.65, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":57806,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549998,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":2602,"price":171.3352,"value":445814.1904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.65 to $171.62, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":61909,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549997,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":901,"price":170.0704,"value":153233.4304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.59 to $170.39, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":64511,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549996,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1959,"price":169.053,"value":331174.827,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.50 to $169.45, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":65412,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549995,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":2801,"price":167.8829,"value":470240.0029,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.31 to $168.27, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":67371,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549994,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1100,"price":166.6236,"value":183285.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.30 to $167.16, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":70172,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549993,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":904,"price":165.683,"value":149777.432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.30 to $166.24, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":71272,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549992,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":703,"price":164.7398,"value":115812.0794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.26 to $165.20, inclusive. The reporting person undertakes to provide to Novavax, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":72176,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549991,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":35000,"price":27,"value":945000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":72879,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2549990,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:04:01.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":14000,"price":27.6,"value":386400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":37879,"source":{"system":"sec-edgar","filing":"0001209191-21-059552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121059552/doc4.xml","form_type":"4"}},{"id":2558076,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-09-28T21:02:02.000Z","date":"2021-09-26","kind":"exercise","acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":6546,"derivative":{"underlying":"Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001209191-21-057939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057939/doc4.xml","form_type":"4"}},{"id":2558075,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-28T21:02:02.000Z","date":"2021-09-26","kind":"tax_withholding","acquired":false,"shares":3162,"price":248.16,"value":784681.92,"ownership":{"direct":true},"balance_after":23879,"source":{"system":"sec-edgar","filing":"0001209191-21-057939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057939/doc4.xml","form_type":"4"}},{"id":2558074,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-28T21:02:02.000Z","date":"2021-09-26","kind":"exercise","acquired":true,"shares":6546,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":27041,"source":{"system":"sec-edgar","filing":"0001209191-21-057939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057939/doc4.xml","form_type":"4"}},{"id":2606719,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:14:19.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.63,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050935","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919121050935/doc4.xml","form_type":"4"}},{"id":2642087,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":27439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F24","text":"The shares subject to this option grant vested in four equal annual installments beginning on the first anniversary of the March 6, 2014 grant date."}],"balance_after":0,"derivative":{"exercise_price":121,"expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":27439},"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642086,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":25120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F23","text":"The shares subject to this option grant vested in four equal annual installments beginning on the first anniversary of the March 2, 2013 grant date."}],"balance_after":0,"derivative":{"exercise_price":36.6,"expiration_date":"2023-03-02","underlying":"Common Stock","underlying_shares":25120},"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642085,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":17560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F24","text":"The shares subject to this option grant vested in four equal annual installments beginning on the first anniversary of the March 6, 2014 grant date."}],"balance_after":27439,"derivative":{"exercise_price":121,"expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":17560},"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642084,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":19879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F23","text":"The shares subject to this option grant vested in four equal annual installments beginning on the first anniversary of the March 2, 2013 grant date."}],"balance_after":25120,"derivative":{"exercise_price":36.6,"expiration_date":"2023-03-02","underlying":"Common Stock","underlying_shares":19879},"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642083,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":15181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F22","text":"The shares subject to this option grant vested in four equal annual installments beginning on the first anniversary of the March 1, 2012 grant date."}],"balance_after":0,"derivative":{"exercise_price":25.6,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":15181},"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642082,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":675,"price":221.5281,"value":149531.4675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.38 to $222.33, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":20495,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642081,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":628,"price":220.8006,"value":138662.7768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.34 to $221.20, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":21170,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642080,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":5031,"price":219.7605,"value":1105615.0755,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.33 to $220.27, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":21798,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642079,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":7423,"price":218.7717,"value":1623942.3291,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.33 to $219.30, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":26829,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642078,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":9969,"price":217.8405,"value":2171651.9445,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.28 to $218.27, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":34252,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642077,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":2994,"price":216.9188,"value":649454.8872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.26 to $217.18, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":44221,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642076,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":5190,"price":215.7406,"value":1119693.714,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.24 to $216.17, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":47215,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642075,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":4466,"price":214.7581,"value":959109.6746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.20 to $215.16, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":52405,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642074,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":2355,"price":213.3849,"value":502521.4395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.87 to $213.84, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":56871,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642073,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":7616,"price":212.2878,"value":1616783.8848000001,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.82 to $212.79, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":59226,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642072,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":4242,"price":211.2084,"value":895946.0328,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.82 to $211.75, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":66842,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642071,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":1970,"price":210.2299,"value":414152.903,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.75 to $210.74, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":71084,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642070,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":27439,"price":121,"value":3320119.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":73054,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642069,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":25120,"price":36.6,"value":919392.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":45615,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}},{"id":2642068,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36307,"kind":"person","name":"Erck Stanley C","position":1,"cik":"0001342826","reported_name":"Erck Stanley C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T21:03:46.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":1329,"price":215.6983,"value":286663.0407,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.63 to $215.84,\ninclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this\nfootnote."}],"balance_after":20495,"source":{"system":"sec-edgar","filing":"0001209191-21-045558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045558/doc4.xml","form_type":"4"}}],"next_cursor":"2021-07-06T21:03:46.000000Z,2642068"}